Table 3.
Complications in the overall and in the matched population
| Overall population | Matched population | |||
|---|---|---|---|---|
| Lipiodol-TACE, n = 160 | DEB-TACE, n = 167 | Lipiodol-TACE, n = 101 | DEB-TACE, n = 101 | |
| Abdominal pain | ||||
| Grade 1–2 | 4 (2.5) | 0 | 2 (2) | 0 |
| Grade 3–4 | 0 | 0 | 0 | 0 |
| Grade 5 | 0 | 0 | 0 | 0 |
| Nausea/vomiting | ||||
| Grade 1–2 | 5 (3.1) | 0 | 1 (1) | 0 |
| Grade 3–4 | 1 (0.6) | 0 | 1 (1) | 0 |
| Grade 5 | 0 | 0 | 0 | 0 |
| Fever | ||||
| Grade 1–2 | 8 (5) | 5 (3) | 6 (6) | 4 (4) |
| Grade 3–4 | 0 | 1 (0.6) | 0 | 0 |
| Grade 5 | 0 | 0 | 0 | 0 |
| Liver dysfunction | ||||
| Grade 1–2 | 21 (13.1) | 3 (1.8) | 13 (12.9) | 3 (3) |
| Grade 3–4 | 0 | 0 | 0 | 0 |
| Grade 5 | 0 | 0 | 0 | 0 |
| Other* | ||||
| Grade 1–2 | 4 (2.5)* | 6 (3.6)° | 3 (3)+ | 2 (2)^ |
| Grade 3–4 | 3 (1.9)** | 6 (3.6)°° | 1 (1)++ | 2 (2)^^ |
| Grade 5 | 1 (0.6)*** | 0 | 0 | 0 |
Data are given as numbers (and percentages)
Other complications included:
*Cholecystitis, hyperglycemia, pleural effusion; vasovagal syndrome
**Cholecystitis, pleural effusion, respiratory failure
***Liver abscess and liver failure
°Transient renal failure, cholecystitis, pleural effusion, pancreatitis, hyperglycemia, allergy to contrast media
°°Abscess formation (n = 2), pancreatitis (n = 2), cholecystitis; groin hematoma
+Cholecystitis, vasovagal syndrome, pleural effusion
++ Pleural effusion
^ Transient renal failure, allergy to contrast media
^^ Groin hematoma, pancreatitis